Prolific Machines vs Tempus
Side-by-side comparison of AI visibility scores, market position, and capabilities
Light-Activated Cell Growth & Biomanufacturing Technology
Prolific Machines is a Berkeley-based biotech company using light to control cell growth and differentiation, dramatically reducing bioreactor costs for cultivated meat and cell therapy; raised $55M+ including a $36M Series B in 2023;
About
Prolific Machines is a Berkeley, California-based biomanufacturing technology company founded in 2020 by Deniz Kent, Joshua Mich, and Declan Jones that has developed a pioneering approach to cell biology: using light — specifically engineered light-sensitive proteins (optogenetics) — to control the growth and differentiation of stem cells and other mammalian cells in bioreactors. Traditional cell culture requires expensive biological growth factors (proteins such as FGF2 and TGF-β) added to culture media to drive cell proliferation and differentiation. Prolific Machines'' technology replaces or dramatically reduces the need for these expensive growth factor inputs by using light signals to activate engineered receptors within cells — achieving the same biological responses at a fraction of the cost.
Publicly traded AI precision medicine company (Nasdaq: TEM); $1.27B revenue in 2025 (+83% YoY); $14B+ market cap; genomic profiling, algorithmic diagnostics, and clinical trial matching across oncology, neurology, and cardiology.
About
Tempus AI is a technology company applying artificial intelligence to advance precision medicine across oncology, neurology, psychiatry, and cardiology. Founded in 2015 by Eric Lefkofsky (co-founder of Groupon) and headquartered in Chicago, Illinois, Tempus built the world's largest library of clinical and molecular data and applies AI to help physicians make more personalized, data-driven treatment decisions. The company's core offerings include genomic profiling (sequencing tumor DNA to identify mutations and actionable targets), algorithmic diagnostic tests (AI-driven companion diagnostics for cancer treatment selection), clinical trial matching (connecting eligible patients to appropriate studies), and data licensing to pharmaceutical and biotech partners for drug discovery and clinical development.
AI Visibility Head-to-Head
Key Details
Also Compare
Prolific Machines vs
Track AI Visibility in Real Time
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.